Technician Histology

Accepting BioReady™: Yes
Category: Clinical Research
Education: Diploma/DEC
Location: Laval, QC
Posted: January 12, 2021
Closes: February 12, 2021

Job description:

For 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we’ll help you build a career that you can feel passionate about.

Job Summary

Performs technical tasks in the conduct of in vivo research studies or support services in accordance with good animal welfare practices. Prepares, collects and records research data and specimens in compliance with applicable regulations and SOPs.

We are seeking a Histology Technician for our Histopathology department site located in Laval (Greater Montreal area) in Canada

The following are responsibilities related to the Histology Technician:

  • Perform techniques required to prepare the slides for the histological evaluation of the animal tissues/organs;
  • Perform Histology tasks such as : tissue trimming, tissue processing using the automatic tissue processor, paraffin embedding, cutting on microtome, manual staining and mounting of slides;
  • Prepare study book; Record all data and fill out appropriate forms during procedure;
  • Prepare shipment and packing of specimens.

The following are minimum qualifications related to the Histology Technician position : 

  • Collegial Diploma in Biology, Biochemistry or equivalent;
  • Reading of English is required. Bilingualism is preferable;
  • Good problem solving and analytical skills;
  • Ability to work under time constraints and adapt to change;
  • Ability to work in a team environment.

About Safety Assessment

Charles River is committed to helping our partners expedite their preclinical drug development with exceptional safety assessment services, state-of-the-art facilities and expert regulatory guidance. From individual specialty toxicology and IND enabling studies to tailored packages and total laboratory support, our deeply experienced team can design and execute programs that anticipate challenges and avoid roadblocks for a smooth, efficient journey to market.  Each year approximately 120 investigational new drug (IND) programs are conducted in our Safety Assessment facilities.

About Charles River

Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.

With over 17,000 employees within 90 facilities in 20 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world. And in 2019, revenue increased to $2.62 billion.

At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of ~85% of the drugs approved by the FDA in 2019.

Apply Now